AMCLEUS

Welcome to the Brand page for “AMCLEUS”, which is offered here for Pharmaceuticals, proteasome inhibitors; and pharmaceutical preparations for treatment of myelomas, leukemias, and cancers; pharmaceutical preparations for use in chemotherapy;.

Its status is currently believed to be active. Its class is unavailable. “AMCLEUS” is believed to be currently owned by “Millennium Pharmaceuticals, Inc.”

Owner:
MILLENNIUM PHARMACEUTICALS, INC.
Owner Details
Description:
Pharmaceuticals, proteasome inhibitors; and pharmaceutical preparations for treatment of myelomas, leukemias, and cancers; pharmaceutical preparations for use in chemotherapy;
Categories: PHARMACEUTICALS